Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.32 |
| ▸ | FAP | Q12884 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serine SCHEMBL5320795 | 0.86 | SLC7A5 (0.39) | SLC7A5SLC15A1 | |
| SCHEMBL5320796 | 0.85 | SLC7A5 (0.33) | SLC7A5 | |
| SCHEMBL442281 | 0.85 | SLC7A5 (0.30) | SLC7A5 | |
| SCHEMBL1535416 | 0.84 | SLC7A5 (0.42) | SLC7A5SLC15A1DPP4FAPDPP8 | |
| SCHEMBL542262 | 0.84 | SLC7A5 (0.42) | SLC7A5SLC15A1DPP4FAPDPP8 | |
| SCHEMBL15658562 | 0.84 | SLC7A5 (0.42) | SLC7A5SLC15A1DPP4FAPDPP8 | |
| SCHEMBL1537296 | 0.82 | GRIN2D (0.33) | SLC7A5 | |
| SCHEMBL186138 | 0.82 | GRIN2D (0.33) | SLC7A5 | |
| SCHEMBL1537300 | 0.82 | DPP4 (0.40) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL1537380 | 0.82 | DPP4 (0.40) | DPP4DPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120123097-A1 | RICIN A CHAIN MUTANTS LACKING ENZYMATIC ACTIVITY AS VACCINES TO PROTECT AGAINST AEROSOLIZED RICIN | VITETTA ELLEN S (US) | 2012-05-17 | — | — | US | claimed |
| US-8114611-B2 | Affinity chromatography matrices and methods of making and using the same | MILLIPORE CORPORATION (US) | 2012-02-14 | — | — | US | claimed |
| US-20110105730-A1 | AFFINITY CHROMATOGRAPHY MATRICES AND METHODS OF MAKING AND USING THE SAME | MILLIPORE CORPORATION (US) | 2011-05-05 | — | — | US | claimed |
| US-20100063261-A1 | Affinity chromatography matrices and methods of making and using the same | MILLIPORE CORPORATION (US) | 2010-03-11 | — | — | US | claimed |
| EP-1974215-A2 | AFFINITY CHROMATOGRAPHY MATRICES AND METHODS OF MAKING AND USING THE SAME | MILLIPORE CORPORATION (US) | 2008-10-01 | — | — | EP | claimed |
| US-20070207500-A1 | Affinity chromatography matrices and methods of making and using the same | MILLIPORE CORPORATION (US) | 2007-09-06 | — | — | US | claimed |
| WO-2007081851-A2 | AFFINITY CHROMATOGRAPHY MATRICES AND METHODS OF MAKING AND USING THE SAME | MILLIPORE CORPORATION (US) | 2007-07-19 | — | — | WO | claimed |
| US-5545621-A | Glutathione S-transferase-activated compounds | TERRAPIN TECHNOLOGIES, INC. (US) | 1996-08-13 | — | — | US | claimed |
| US-11224647-B2 | Safe potent single platform vaccine against Tier 1 select agents and other pathogens | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-01-18 | — | — | US | disclosed |
| US-10837027-B2 | Further improved AAV vectors produced in insect cells | UNIQURE IP B.V. (NL) | 2020-11-17 | — | — | US | disclosed |
| US-20190322702-A1 | Tricalcium Phosphate Binding Peptides And Uses Thereof | ALVAREZ, LUIS | 2019-10-24 | — | — | US | disclosed |
| US-20190240310-A1 | SAFE POTENT SINGLE PLATFORM VACCINE AGAINST TIER 1 SELECT AGENTS AND OTHER PATHOGENS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-08-08 | — | — | US | disclosed |
| US-10329327-B2 | Tricalcium phosphate binding peptides and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-06-25 | — | — | US | disclosed |
| EP-3490594-A1 | SAFE POTENT SINGLE PLATFORM VACCINE AGAINST TIER 1 SELECT AGENTS AND OTHER PATHOGENS | The Regents of the University of California (US) | 2019-06-05 | — | — | EP | disclosed |
| US-5196321-A | Gene expression; splitting with protease | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-03-23 | — | — | US | disclosed |
| US-5132213-A | Peptide fusion for genetic engineering and protein synthesis | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-07-21 | — | — | US | disclosed |
| US-5093242-A | Ubiquitin-protein fusions, stability | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-03-03 | — | — | US | disclosed |
| EP-0408661-A1 | METHODS OF GENERATING DESIRED AMINO-TERMINAL RESIDUES IN PROTEINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-01-23 | — | — | EP | disclosed |
| WO-1989009829-A2 | METHODS OF GENERATING DESIRED AMINO-TERMINAL RESIDUES IN PROTEINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-10-19 | — | — | WO | disclosed |
| EP-0324789-A1 | METHODS OF REGULATING METABOLIC STABILITY OF PROTEINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-07-26 | — | — | EP | disclosed |